Mario Amzel
Johns Hopkins University School of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mario Amzel.
Journal of Biological Chemistry | 2002
Michelle A. Poirier; Huilin Li; Jed C. Macosko; Shuowei Cai; Mario Amzel; Christopher A. Ross
The pathology of Huntingtons disease is characterized by neuronal degeneration and inclusions containing N-terminal fragments of mutant huntingtin (htt). To study htt aggregation, we examined purified htt fragments in vitro, finding globular and protofibrillar intermediates participating in the genesis of mature fibrils. These intermediates were high in β-structure. Furthermore, Congo Red, a dye that stains amyloid fibrils, prevented the assembly of mutant htt into mature fibrils, but not the formation of protofibrils. Other proteins capable of forming ordered aggregates, such as amyloid β and α-synuclein, form similar intermediates, suggesting that the mechanisms of mutant htt aggregation and possibly htt toxicity may overlap with other neurodegenerative disorders.
Proceedings of the National Academy of Sciences of the United States of America | 2003
Christopher A. Ross; Michelle A. Poirier; Erich E. Wanker; Mario Amzel
Nine neurodegenerative diseases are caused by expanding CAG repeats coding for polyglutamine (polyGln) (1–4). These include Huntingtons disease, dentatorubral and pallidoluysian atrophy, several forms of spino-cerebellar ataxia, and spinal and bulbar muscular atrophy. Within the central nervous system, each disease has a distinctive pattern of degeneration, with considerable overlap among the diseases (5, 6). The genes containing CAG repeats show no homology to each other outside of the glutamine repeats, and most are genes of unknown function. Thus, speculation concerning pathogenesis has focused on the polyGln expansion itself.
Journal of Biological Chemistry | 2011
Qi Charles Zhang; Tzu Lan Yeh; Alfonso Leyva; Leslie G. Frank; Jason Miller; Yujin E. Kim; Ralf Langen; Steven Finkbeiner; Mario Amzel; Christopher A. Ross; Michelle A. Poirier
Huntington disease results from an expanded polyglutamine region in the N terminus of the huntingtin protein. HD pathology is characterized by neuronal degeneration and protein inclusions containing N-terminal fragments of mutant huntingtin. Structural information is minimal, though it is believed that mutant huntingtin polyglutamine adopts β structure upon conversion to a toxic form. To this end, we designed mammalian cell expression constructs encoding compact β variants of Htt exon 1 N-terminal fragment and tested their ability to aggregate and induce toxicity in cultured neuronal cells. In parallel, we performed molecular dynamics simulations, which indicate that constructs with expanded polyglutamine β-strands are stabilized by main-chain hydrogen bonding. Finally, we found a correlation between the reactivity to 3B5H10, an expanded polyglutamine antibody that recognizes a compact β rich hairpin structure, and the ability to induce cell toxicity. These data are consistent with an important role for a compact β structure in mutant huntingtin-induced cell toxicity.
Molecular Biology of the Cell | 1998
Tian Jin; Mario Amzel; Peter N. Devreotes; Lijun Wu
FEBS Journal | 2003
Andreas G. Tzakos; Alexandre M. J. J. Bonvin; Anasstasios Troganis; Paul Cordopatis; Mario Amzel; Ioannis P. Gerothanassis; Nico A. J. van Nuland
Proteins | 1986
Srinivasan Chandrasegaran; Hamilton O. Smith; Mario Amzel; Xavier Ysern
Archive | 2016
Christopher A. Ross; Michelle A. Poirier; Erich Wanker; Mario Amzel; Max Perutz
Biophysical Journal | 2015
Sandra B. Gabelli; Agedi N. Boto; Victoria Halpernin; Mario A. Bianchet; Federica Farinelli; Jesse B. Yoder; Jean Jakoncic; Gordon F. Tomaselli; Mario Amzel
Biophysical Journal | 2015
Silvia Ravera; Matthias Quick; Juan Pablo Nicola; Nancy Carrasco; Mario Amzel
Biophysical Journal | 2011
Sandra B. Gabelli; Eric Oldfield; Dolores Gonzalez Pacanowska; Mario Amzel